
Cytax 200mg Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Paclitaxel (200mg)
Overview Cytax 200mg Injection
OncoCyte-200 injection is a chemotherapy agent indicated for treating breast, pancreatic, and non-small-cell lung cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's prescribed regimen; incorrect usage or overdose can lead to severe complications. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include nausea, vomiting, and fatigue. Serious side effects like edema (hand and lip swelling), alopecia, and weight increase are possible. Your doctor might prescribe additional medications to mitigate side effects. Report any unusual bruising, bleeding, sore throat, mouth sores, or fever immediately. This medication can lower blood cell counts (red and white), raising infection risk. Regular blood tests to monitor blood cell levels and liver function are necessary. Prior to treatment, inform your physician of any heart, liver, or kidney issues, and all medications you're taking, including antibiotics, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Uses of Cytax 200mg Injection
Cancers of the breast, lung (non-small cell type), and pancreas.
Major Benefits of Cytax 200mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cytax 200mg Injection:
- Nausea
- Vomiting
- Weakness
- Low blood platelets
- Rash
- Upper respiratory tract infection
- Urinary tract infection
- Bleeding
- Anemia (low number of red blood cells)
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Hair loss
- Decreased blood pressure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
- Decreased white blood cell count (neutrophils)
How to use Cytax 200mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Cytax 200mg Injection works:
Cytax 200mg Injection is a cancer treatment that disrupts microtubule formation, essential for cancer cell division and proliferation. This action inhibits cancerous growth, ultimately leading to cell death.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Cytax 200mg Injection is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Cytax 200mg Injection during pregnancy is contraindicated due to established risks to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Cytax 200mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Studies indicate a risk of harm to the nursing infant.
DrivingUNSAFE
Cytax 200mg Injection can produce adverse reactions that might impair your driving ability. While there's no inherent prohibition against driving between treatment cycles with Cytax 200mg Injection, consider that this medication includes alcohol, which could make driving inadvisable.
KidneySAFE IF PRESCRIBED
Administration of Cytax 200mg Injection is considered safe for individuals with impaired renal function. No modification of the Cytax 200mg Injection dosage is necessary. Nevertheless, consultation with a physician is advised for patients with pre-existing kidney conditions.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Cytax 200mg Injection, as dose modification may be necessary. Consult a physician for guidance. Cytax 200mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Cytax 200mg Injection :
NA
Facts to Know About Cytax 200mg Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane-Based Drugs |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
